Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety (Q34227698)

31 July 2017

1 reference

title

Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety (English)

1 reference

medroxyprogesterone acetate

31 July 2017

main subject

1 reference

1

Carolyn Westhoff

1 reference

31 July 2017

language of work or name

1 reference

1 August 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

68

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

75-87

1 reference

Trends in contraceptive use in the United States: 1982-1995

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Unintended Pregnancy in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Oral contraception noncompliance: the extent of the problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Reduced risk of pelvic inflammatory disease with injectable contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

In Utero Exposure to Steroid Contraceptives and Outcome of Pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Injectable contraception. New and existing options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Women's reproductive cancers in evolutionary context

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Menstruation: choosing whether...and when

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Menstruation, sex hormones, and migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Medroxyprogesterone acetate and homozygous sickle-cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Treatment of seizures with medroxyprogesterone acetate: preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Myocardial infarction in users of low-dose oral contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Stroke in users of low-dose oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Use of low-dose oral contraceptives and stroke in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Effects of DMPA on weight and blood pressure in long-term acceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Low-dose oral contraceptives and 24-hour ambulatory blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Breast cancer risk: perception versus reality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Oral contraceptives and the risk of breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

History of long-term use of depot-medroxyprogesterone acetate in patients with cervical dysplasia; case-control analysis nested in a cohort study. The New Zealand Contraception and Health Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Inhibition of ovulation with transdermal estradiol and oral progestogens in perimenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Cervical cancer and use of hormonal contraceptives: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Oral contraceptives and cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Injectable hormone contraception and bone density: results from a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Long-term depot-medroxyprogesterone acetate and bone mineral density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

The impact of lifestyle factors on stress fractures in female Army recruits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Prevalence and Trends in Obesity Among US Adults, 1999-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Weight change in adolescents who used hormonal contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

A multicentered clinical trial of the long-acting injectable contraceptive Depo Provera in Chinese women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Physical findings and symptoms of depot medroxyprogesterone acetate use in adolescent females.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Depo-provera associated with weight gain in Navajo women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Depomedroxyprogesterone acetate use and weight gain among adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Short-term effects of a progestational contraceptive drug on food intake, resting energy expenditure, and body weight in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Weight gain in adolescent and young adult oral contraceptive users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Depression in users of depo-medroxyprogesterone acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Depressive symptoms and Depo-Provera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Depressive symptoms in users and non-users of depot medroxyprogesterone acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

To what extent do oral contraceptives influence mood and affect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Experiences of injectable contraceptive users in an urban setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Attitudes to current oral contraceptive use and future developments: the women's perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Contraceptive efficacy and patient acceptance of Lunelle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Nuisance or natural and healthy: should monthly menstruation be optional for women?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Steroid contraceptive use and pregnancy outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Contraceptive failure in the United States: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Hormonal manipulation in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900136-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-7824(03)00136-7

1 reference

31 July 2017

1 reference